University of
Oxford
University of Oxford contributes leadership in health economics to the IMPROVE PRETERM project, supporting the development of economic evaluation frameworks for comparative effectiveness research. This work is carried out by the Health Economics and Policy Evaluation Group within the Nuffield Department of Primary Care Health Sciences (NDPCHS).
The group conducts high-quality research on the economic dimensions of health and healthcare in the UK and internationally. Its researchers apply a wide range of economic approaches to understand and improve healthcare delivery, population health, and well-being across diverse settings.
Stavros Petrou, who leads the group, oversees the health economic components of IMPROVE PRETERM, ensuring that economic evidence is rigorously integrated into the project’s analyses and policy-relevant outputs.
Stavros Petrou
Stavros Petrou is the Academic Lead in Health Economics and Professor of Health Economics at the Nuffield Department of Primary Care Health Sciences, University of Oxford. His research portfolio draws from a diverse funding base and covers both policy-relevant economic evaluations of diverse interventions, and methodological work. A core theme of his research over the past 25 years has been the study of economic aspects of perinatal and paediatric health and health care, encompassing trial-based economic evaluations, economic evaluations based on decision-analytic models, systematic reviews, preference elicitation studies, and analyses of both cross-sectional data and cohort study data using econometric techniques. He is overseeing the health economic components of IMPROVE PRETERM, ensuring that economic evidence is rigorously integrated into the project’s analyses and policy-relevant outputs.
Corneliu Bolbocean
Senior Researcher in Health Economics at the Nuffield Department of Primary Care Health Sciences, University of Oxford. My research focuses on health-related quality of life measurement, economic evaluation, and long-term outcomes of preterm birth, using individual participant data meta-analyses across European cohorts. Within IMPROVE PRETERM, I supervise Oxford’s contribution to the health economics work package.